サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：頭頸部がん治療薬の世界市場：市場規模、市場シェア、動向分析、機会、予測：タイプ別、治療タイプ別、投与経路別、エンドユーザー別、地域別（2018年～2028年）
市場調査レポート
商品コード
1172560

頭頸部がん治療薬の世界市場：市場規模、市場シェア、動向分析、機会、予測：タイプ別、治療タイプ別、投与経路別、エンドユーザー別、地域別（2018年～2028年）

Head and Neck Cancer Therapeutics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018-2028, Segmented By Type ; Treatment Type ; Route of Administration ; By End-User ; Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 254 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
頭頸部がん治療薬の世界市場：市場規模、市場シェア、動向分析、機会、予測：タイプ別、治療タイプ別、投与経路別、エンドユーザー別、地域別（2018年～2028年）
出版日: 2022年12月06日
発行: Blueweave Consulting
ページ情報: 英文 254 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の頭頸部がん治療薬の市場規模は、2021年の11億米ドルから2028年には約26億米ドルに達し、予測期間中に12.6%のCAGRで成長すると予測されています。バイオシミラーや早期診断法の利用の増加、積極的な医療改革は、市場の成長を促進しています。

当レポートでは、世界の頭頸部がん治療薬市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の頭頸部がん治療薬市場の洞察

  • 業界バリューチェーン分析
  • DROC分析
    • 促進要因
      • バイオシミラーの使用の増加
      • 早期診断法の台頭
      • 前向きなヘルスケア改革
    • 抑制要因
      • 重大な薬の副作用
      • その他
    • 機会
      • 頭頸部がん治療の併用療法に対する需要の増加
      • その他
    • 課題
      • 高い治療費
      • その他
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争の激しさ

第4章 世界の頭頸部がん治療市場概要

  • 市場規模と予測（2018年～2028年）：金額別
    • 金額別（100万米ドル）
  • 市場シェアと予測
    • タイプ別
      • 診断
      • 治療
    • 治療タイプ別
      • 適応症別
    • 投与経路別
      • 注射
      • 経口
    • エンドユーザー別
      • 病院
      • 専門クリニック
      • 外来手術センター
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東とアフリカ

第5章 北米の頭頸部がん治療薬市場

第6章 欧州の頭頸部がん治療薬市場

第7章 アジア太平洋地域の頭頸部がん治療薬市場

第8章 ラテンアメリカの頭頸部がん治療薬市場

第9章 中東およびアフリカの頭頸部がん治療薬市場

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 市場シェア分析（2021年）
  • 競合ベンチマーキング：操作パラメータ別
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の頭頸部がん治療薬市場に対するCOVID-19の影響

第12章 企業プロファイル（企業概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先、SWOT、および戦略的展望）**

  • Pfizer INC
  • Eli Lilly and Company
  • Sun Pharmaceutical Industries Limited
  • Intas Pharmaceuticals Ltd
  • Glaxosmithkline PLC
  • Novartis International AG
  • Sanofi
  • Bayer AG
  • Hoffmann-LA Roche AG
  • Merck & co., INC
  • Astrazenica PLC
  • Teva Pharmaceutical Industries Ltd.
  • その他

第13章 主要な戦略的推奨事項

第14章 調査手法

注：最終納品物では、上記以外の企業の財務情報はデータが利用でき次第、提供されます。

最終納品物では、セグメンテーションおよび企業は、詳細な補足情報により変更される可能性があります。

図表

List of Figures

  • Figure 1: Global Head and Neck Cancer Therapeutics Market Segmentation
  • Figure 2: Global Head and Neck Cancer Therapeutics Market Industry Value Chain Analysis
  • Figure 3: Global Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 4: Global Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028
  • Figure 5: Global Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028
  • Figure 6: Global Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028
  • Figure 7: Global Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028
  • Figure 8: Global Head and Neck Cancer Therapeutics Market Share (%), By Region, By Value, 2018-2028
  • Figure 9: North America Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 10: North America Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028
  • Figure 11: North America Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028
  • Figure 12: North America Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028
  • Figure 13: North America Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028
  • Figure 14: North America Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028
  • Figure 15: Europe Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 16: Europe Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028
  • Figure 17: Europe Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028
  • Figure 18: Europe Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028
  • Figure 19: Europe Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028
  • Figure 20: Europe Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028
  • Figure 21: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 22: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028
  • Figure 23: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028
  • Figure 24: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028
  • Figure 25: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028
  • Figure 26: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028
  • Figure 27: Latin America Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 28: Latin America Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028
  • Figure 29: Latin America Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028
  • Figure 30: Latin America Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028
  • Figure 31: Latin America Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028
  • Figure 32: Latin America Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028
  • Figure 33: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028
  • Figure 34: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028
  • Figure 35: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028
  • Figure 36: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028
  • Figure 37: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028
  • Figure 38: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028
  • Figure 39: Global Head and Neck Cancer Therapeutics Market Share Analysis, 2021

List of Tables

  • Table 1: Global Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 2: Global Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), 2018-2028
  • Table 3: Global Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), 2018-2028
  • Table 4: Global Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 5: Global Head and Neck Cancer Therapeutics Market Size. By Region, By Value (USD Million), 2018-2028
  • Table 6: North America Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 7: North America Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), 2018-2028
  • Table 8: North America Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), 2018-2028
  • Table 9: North America Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 10: North America Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028
  • Table 11: Europe Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 12: Europe Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), By Value 2018-2028
  • Table 13: Europe Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), By Value 2018-2028
  • Table 14: Europe Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), By Value 2018-2028
  • Table 15: 40 Europe Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028
  • Table 16: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 17: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By Type, By Value 2018-2028
  • Table 18: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By Treatment Type, By Value 2018-2028
  • Table 19: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By Route of Administration, By Value 2018-2028
  • Table 20: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By End-User, By Value 2018-2028
  • Table 21: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028
  • Table 22: Latin America Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), By Value 2018-2028
  • Table 23: Latin America Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), 2018-2028
  • Table 24: Latin America Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), 2018-2028
  • Table 25: Latin America Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 26: Latin America Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028
  • Table 27: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), 2018-2028
  • Table 28: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), 2018-2028
  • Table 29: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), 2018-2028
  • Table 30: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), 2018-2028
  • Table 31: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028
  • Table 32: List of Key Players and Their Offerings
  • Table 33: Competitive Benchmarking, by Operating Parameters
  • Table 34 Pfizer INC Company Overview
  • Table 35 Pfizer INC Financial Overview
  • Table 36 Lilly Company Overview
  • Table 37 Lilly Financial Overview
  • Table 38 Sun Pharmaceutical Industries Limited Company Overview
  • Table 39 Sun Pharmaceutical Industries Limited Financial Overview
  • Table 40 Intas Pharmaceuticals Ltd Company Overview
  • Table 41 Intas Pharmaceuticals Ltd Financial Overview
  • Table 42 Glaxosmithkline PLC Company Overview
  • Table 43 Glaxosmithkline PLC Financial Overview
  • Table 44 Novartis International AG Company Overview
  • Table 45 Novartis International Financial Overview
  • Table 46 Sanofi Company Overview
  • Table 47 Sanofi Financial Overview
  • Table 48 Bayer AG Company Overview
  • Table 49 Bayer AG Financial Overview
  • Table 50 Hoffmann -LA Roche AG Company Overview
  • Table 51 Hoffmann -LA Roche AG Financial Overview
  • Table 52 Merck & Co., INC Company Overview
  • Table 53 Merck & Co., INC Financial Overview
  • Table 54 Astrazenica PLC Company Overview
  • Table 55 Astrazenica PLC Financial Overview
  • Table 56 Teva Pharmaceutical Industries LTD Company Overview
  • Table 57 Teva Pharmaceutical Industries LTD Financial Overview
目次
Product Code: BWC22576

Global Head and Neck Cancer Therapeutics Market to Grow at a CAGR of 12.6% during Forecast Period.

Global Head and Neck Cancer Therapeutics Market is growing at a high CAGR because of the rising use of biosimilars and early diagnostic methods as well as positive healthcare reforms.

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Head and Neck Cancer Therapeutics Market was worth USD 1.1 billion in the year 2021. The market is projected to grow at a CAGR of 12.6% from 2022-2028 (forecast period), earning revenues of around USD 2.6 billion by the end of 2028. The Global Head and Neck Cancer Therapeutics Market is booming because of the rising demand for consumer electronic items like smartphones, televisions, and digital cameras, as well as the increased manufacturing of electric cars. In addition, rising demand for IoT devices is emerging as a significant driver of market expansion. However, high dependence on other countries for semiconductor chip imports may act as a huge restraining factor for market growth.

Increased demand for a combination treatment for head and neck cancer care

Increases in the prevalence of specific diseases and the availability of better healthcare thanks to public and private sector initiatives are all expected to propel the industry forward in the next years. The global market for head and neck cancer treatments is growing as a result of several factors, including the rising incidence of this disease worldwide, the rising preference for multimodal approaches to care, and the rising emphasis on research and development to identify the most effective clinical therapy.

In addition, an increase in risk factors such as alcohol, cigarette smoking, and tobacco use is anticipated to contribute to the growing worldwide need for head and neck cancer treatments.

Challenge

High treatment costs

Market growth is anticipated to be stymied by the high expenses associated with the treatment plan, the unfavorable reactions of alternative treatment alternatives, the dearth of insurance services, and the inadequate healthcare system in low- and middle-income countries. Moreover, this patient population faces major issues, such as morbidity and bad quality of life, as a direct result of the incapacitating impact of normal healthcare practices.

Segmental Coverage

Global Head and Neck Cancer Therapeutics Market - By End-User

On the basis of end-user segmentation, the Global Head and Neck Cancer Therapeutics Market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others. Whereby hospitals and specialty clinics take a sizable amount in market share. Due to simple access to medications and inexpensive distribution costs, producers are very likely to distribute their goods, which explains the dominance. According to the Drug Channels Institute's research, the top five specialty pharmacies in the globe in 2021 were Humana specialty pharmacy, Accredo, CVS Specialty, Walgreens stores, and Optum specialty pharmacy.

Global Head and Neck Cancer Therapeutics Market - By Region

The global market for head and neck cancer therapies is divided into five primary regions based on geographical presence. These regions are North America, Europe, The Asia Pacific, Latin America, the Middle East, and Africa. The high frequency of HPV-induced malignancies and the high smoking rate in North America will continue to provide the region with a dominant position in the worldwide head and neck cancer treatment market. It is anticipated that Europe will hold the second biggest market share in the global market for head and neck cancer therapies.

Impact of COVID-19 on Global Head and Neck Cancer Therapeutics Market

The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) that produced the 2019 coronavirus disease (COVID-19) pandemic poses a unique challenge to the world's healthcare infrastructure, including the Global Head and Neck Cancer Therapeutics Market. Standardized treatment for cancer patients was a part of this difficulty. During this time, most in-hospital cancer treatments were discontinued, and only select patients were given radiation therapy with the goal of curing them in accordance with strict protocols to ensure their safety, thereby leading to disturbances and inconveniences in the Global Head and Neck Cancer Therapeutics Market.

Competitive Landscape

Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Ltd., GlaxoSmithKline PLC, Novartis International AG, Sanofi, Bayer AG, Hoffmann-LA Roche AG, Merck & co., INC., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., and Other Prominent Players are active in this industry. AstraZeneca and Pfizer are expected to benefit from the approval of Imfinzi and Bavencio during the projection period. Sanofi and Eli Lilly have been affected by expiring patents and biosimilar medicine competition. Several market participants are expected to collaborate on meeting unmet requirements, discovering novel targets, and developing stronger treatment pipelines.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Head and Neck Cancer Therapeutics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Head and Neck Cancer Therapeutics Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Head and Neck Cancer Therapeutics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising Biosimilar Use
      • 3.2.1.2. Rise in early Diagnostic Methods
      • 3.2.1.3. Positive Healthcare Reforms
    • 3.2.2. Restraints
      • 3.2.2.1. Frequent failure at the end of the process, Substantial medication adverse effects are a fact of life
      • 3.2.2.2. Others
    • 3.2.3. Opportunities
      • 3.2.3.1. Increased demand for a combination treatment for head and neck cancer care
      • 3.2.3.2. Others
    • 3.2.4. Challenges
      • 3.2.4.1. High Treatment Cost
      • 3.2.4.2. Others
  • 3.3. Technological Advancement/Recent Development
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Head and Neck Cancer Therapeutics Market Overview

  • 4.1. Market Size & Forecast by Value, 2018-2028
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Diagnostic Method
      • 4.2.1.1.1. Biopsy
      • 4.2.1.1.2. Imaging
      • 4.2.1.1.3. Endoscopy
      • 4.2.1.1.4. Others
      • 4.2.1.2. Treatment
      • 4.2.1.2.1. Surgery
      • 4.2.1.2.2. Radiation Therapy
      • 4.2.1.2.3. Chemotherapy
      • 4.2.1.2.4. Immunotherapy
      • 4.2.1.2.5. Targeted Therapy
    • 4.2.2. By Treatment Type
      • 4.2.2.1. By Disease Indication
      • 4.2.2.1.1. Lip and Oral Cavity Cancer
      • 4.2.2.1.2. Laryngeal Cancer
      • 4.2.2.1.3. Oropharyngeal Cancer
      • 4.2.2.1.4. Salivary Gland Cancer
      • 4.2.2.1.5. Nasopharyngeal Cancer
      • 4.2.2.1.6. Hypopharyngeal Cancer
    • 4.2.3. By Route of Administration
      • 4.2.3.1. Injectable
      • 4.2.3.2. Oral
    • 4.2.4. By End-User
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Specialty Clinics
      • 4.2.4.3. Ambulatory Surgical Centers
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. The Asia Pacific
      • 4.2.5.4. Latin America
      • 4.2.5.5. The Middle East and Africa

5. North America Head and Neck Cancer Therapeutics Market

  • 5.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Treatment Type
    • 5.2.3. By Route of Administration
    • 5.2.4. By End-User
    • 5.2.5. By Country
      • 5.2.5.1. United Type
      • 5.2.5.2. Canada

6. Europe Head and Neck Cancer Therapeutics Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Treatment Type
    • 6.2.3. By Route of Administration
    • 6.2.4. By End-User
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.2. United Kingdom
      • 6.2.5.3. Italy
      • 6.2.5.4. France
      • 6.2.5.5. Spain
      • 6.2.5.6. Rest of Europe

7. The Asia Pacific Head and Neck Cancer Therapeutics Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Treatment Type
    • 7.2.3. By Route of Administration
    • 7.2.4. By End-User
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.2. India
      • 7.2.5.3. Japan
      • 7.2.5.4. South Korea
      • 7.2.5.5. Australia
      • 7.2.5.6. Indonesia
      • 7.2.5.7. Singapore
      • 7.2.5.8. Malaysia
      • 7.2.5.9. Rest of Asia Pacific

8. Latin America Head and Neck Cancer Therapeutics Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Treatment Type
    • 8.2.3. By Route of Administration
    • 8.2.4. By End-User
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.2. Mexico
      • 8.2.5.3. Argentina
      • 8.2.5.4. Rest of Latin America

9. The Middle East & Africa Head and Neck Cancer Therapeutics Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Treatment Type
    • 9.2.3. By Route of Administration
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.2. UAE
      • 9.2.5.3. South Africa
      • 9.2.5.4. Iran
      • 9.2.5.5. Nigeria
      • 9.2.5.6. Egypt
      • 9.2.5.7. Turkey
      • 9.2.5.8. Rest of Middle East & Africa

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Market Share Analysis, 2021
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Head and Neck Cancer Therapeutics Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, SWOT, and Strategic Outlook) **

  • 12.1. Pfizer INC
  • 12.2. Eli Lilly and Company
  • 12.3. Sun Pharmaceutical Industries Limited
  • 12.4. Intas Pharmaceuticals Ltd
  • 12.5. Glaxosmithkline PLC
  • 12.6. Novartis International AG
  • 12.7. Sanofi
  • 12.8. Bayer AG
  • 12.9. Hoffmann-LA Roche AG
  • 12.10. Merck & co., INC
  • 12.11. Astrazenica PLC
  • 12.12. Teva Pharmaceutical Industries Ltd.
  • 12.13. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents
  • 14.5. Assumptions & Limitations

Note: Financial in information in case of non-listed companies will be provided as per availability

The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable